What is Pharmacovigilance?

Drugs are an integral part of healthcare. New medications are constantly developed and tested by pharmaceutical companies to be put on the market. However, according to the American Society of Pharmacovigilance, adverse drug events annually account for: 1 million emergency department visits, 2.2 million hospital admissions, 3.5 million physician office visits, and $136 billion in U.S. health care costs. Thus, it is paramount that these drugs are as safe they can be.

Pharmacovigilance (PV), or drug safety, is the study of a drug’s adverse reactions. PV professionals work in varying specialties to ensure that a drug is safe and tested before it can be consumed by the masses.

Why is PV Important?

A drug needs to be approved by the appropriate regulatory body before going on the market. In the U.S., the FDA determines what drugs are ready for the market. Before a drug can apply for FDA approval, it must undergo three phases of clinical trials. Every proceeding phase involves more people and more risk. Thus, it is important for the clinical research team and pharmaceutical company to be sure that a drug is safe before proceeding with the next phase.

What Roles are in PV?

In clinical research, PV operations work with the clinical research team to collect information on a drug’s SAE and ADR. SAE is a serious adverse event. They can be lethal or cause disabilities in the patient or induce birth defects. On the other hand, ADR is an adverse drug reaction, which is a milder adverse reaction to a drug. They include conditions like headaches, nausea, or fatigue.

In addition to data collection, operations are responsible for creating standard operating procedures (SOPs), as well as individual case study reports, literature screening, and regulatory expedited reporting on Suspected unexpected serious adverse reactions (SUSARs), or unknown as unexpected serious adverse reactions, after the drugs are on the market. Those interested in a deeper dive into standard operating procedures and case studies might consider exploring the ICH-GCP course.

The safety data collected by the operations division is maintained by those in the PV systems. They ensure that the data is organized and accessible to research collaborators. The systems team is always working to improve and maintain the vast data, since field regulations and expectations are always changing.

The safety data is then handed to the PV surveillance team. PV surveillance analyzes the safety data and then compiles their analysis into development safety update reports (DSURs). This report determines whether or not the drug is safe enough to move on to the next phase of clinical research. At the end of the third phase, if the drug is safe enough, the PV will submit the drug for FDA approval. Professionals aiming to oversee such critical roles in drug safety might be interested in the Advanced Clinical Research Project Manager Certification.

How Do I Start?

The PV department needs and recruits diverse talents to ensure that a drug is safe. If you can see yourself in one of these positions, then you should absolutely consider a career in PV. CCRPS recently launched our pharmacovigilance course to help aspiring professionals learn about the field and stand out in front of employers. If you want to learn more about pharmacovigilance, please visit our website at CCRPS.Org and chec.

Take courses from CCRPS and learn more on how to become a clinical research professional.

Discover more from Clinical Research Training | Certified Clinical Research Professionals Course